Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle Children’s, and UW Medicine complete restructuring of partnership

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

Personalis Inc. and Tempus AI Inc. have expanded and extended their strategic collaboration, adding a new indication, colorectal cancer, to the existing, exclusive commercialization agreement.

July 11, 2025

Vol.51 No.27

In the Archives

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

When the Women’s Health Initiative was announced in 1991, it was set to be the largest women’s health study ever conducted. The WHI scope is massive: the initiative has recruited more than 161,000 women and engaged more than 5,000 scientists from the U.S. and beyond.

July 03, 2025

Vol.51 No.26

In Brief

Ric Anderson, Eduardo Peñalver named to Fred Hutch board of directors, Jim Lico becomes member

Ric AndersonEduardo PeñalverJim LicoRic Anderson was elected chair of the Fred Hutchinson Cancer Center’s board of directors, and Eduardo Peñalver was named vice chair, effective July 1.

June 27, 2025

Vol.51 No.25

In Brief

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

2025 Dr. Eddie Méndez Scholar Award Recipients, top row left to right: Caitlin Cornell, PhD, Elizabeth Kaweesa, PhD, Leandro Fernández-García, PhD, Almudena Chaves Pérez, PhD. Bottom row left to right: Luis Cedeño-Rosario, PhD, Nicole Halmai, PhD, Megan E. Meuser, PhD, Sarah Elisabeth Pierce, PhD. Fred Hutch Cancer Center has announced eight recipients of the 2025 Dr. Eddie Méndez Scholar Award.

June 20, 2025

Vol.51 No.24

In Brief

Fred Hutch opens science learning lab for students

Fred Hutchinson Cancer Center is opening a new science education lab on its South Lake Union campus, supported by Alexandria Real Estate Equities Inc.

May 30, 2025

Vol.51 No.21

Drugs & Targets

RyboDyn expands strategic cancer immunotherapy collaboration with Moffitt Cancer Center

RyboDyn, Inc. announced on May 15 the expansion of its strategic collaboration with Moffitt Cancer Center, a global leader in cancer care and research.

May 16, 2025

Vol.51 No.19

Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle Children’s, and UW Medicine complete restructuring of partnership

YOU MAY BE INTERESTED IN

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

Ric Anderson, Eduardo Peñalver named to Fred Hutch board of directors, Jim Lico becomes member

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

Fred Hutch opens science learning lab for students

RyboDyn expands strategic cancer immunotherapy collaboration with Moffitt Cancer Center

Renew today!

Subscriber content

Never miss an issue!

Login